BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7729719)

  • 1. [Activity of cathepsin B and D in blood serum of women with uterine cervix neoplasms].
    Makarewicz R; Drewa G; Szymański W
    Ginekol Pol; 1994 Oct; 65(10):578-81. PubMed ID: 7729719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cathepsin B in predicting the extent of the cervix carcinoma.
    Makarewicz R; Drewa G; Szymanski W; Skonieczna-Makarewicz I
    Neoplasma; 1995; 42(1):21-4. PubMed ID: 7617069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A possible application of cathepsin B activity determination for estimating the spread of the cervix uteri carcinoma.
    Makarewicz R; Drewa G
    Acta Biochim Pol; 1996; 43(3):521-4. PubMed ID: 8922036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cathepsin B and antiproteases in patients with carcinoma of the cervix.
    Benítez-Bribiesca L; Freyre-Horta R; Gallegos-Vargas G; de la Huerta-Sánchez R; Alfaro-Aceves L
    Arch Invest Med (Mex); 1981; 12(4):517-37. PubMed ID: 7332393
    [No Abstract]   [Full Text] [Related]  

  • 5. Elevated serum cathepsin B1-like activity in women with neoplastic disease.
    Pietras RJ; Szego CM; Mangan CE; Seeler BJ; Burtnett MM
    Gynecol Oncol; 1979 Feb; 7(1):1-17. PubMed ID: 374195
    [No Abstract]   [Full Text] [Related]  

  • 6. Cytoenzymologic investigations on carcinomas of the cervix uteri.
    Duţu R; Nedelea M; Veluda G; Burculeţ V
    Acta Cytol; 1980; 24(2):160-6. PubMed ID: 6929150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cathepsin D, B and L circulating levels as prognostic markers of malignant progression.
    Tumminello FM; Leto G; Pizzolanti G; Candiloro V; Crescimanno M; Crosta L; Flandina C; Montalto G; Soresi M; Carroccio A; Bascone F; Ruggeri I; Ippolito S; Gebbia N
    Anticancer Res; 1996; 16(4B):2315-9. PubMed ID: 8694562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutathione S-transferase pi is expressed in (pre) neoplastic lesions of the human uterine cervix irrespective of their degree of severity.
    Martens JE; Smedts F; ter Harmsel B; Helmerhorst TJ; Ramaekers FC
    Anticancer Res; 1997; 17(6D):4305-9. PubMed ID: 9494525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cathepsin B-like enzymes. Subcellular distribution and properties in neoplastic and control cells from human ectocervix.
    Pietras RJ; Roberts JA
    J Biol Chem; 1981 Aug; 256(16):8536-44. PubMed ID: 7263668
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of serum cathepsin B and D in relation to clinicopathological staging of colorectal cancer.
    Skrzydlewska E; Sulkowska M; Wincewicz A; Koda M; Sulkowski S
    World J Gastroenterol; 2005 Jul; 11(27):4225-9. PubMed ID: 16015694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Glycolytic enzymatic activity of the cervical epithelium in diseases].
    Tselikovskaia TT; Bykov EG; Kozachenko VP
    Akush Ginekol (Mosk); 1978 Dec; (12):15-8. PubMed ID: 736226
    [No Abstract]   [Full Text] [Related]  

  • 12. Semiquantitative analysis of telomerase activity in cervical cancer and precancerous lesions.
    Nagai N; Oshita T; Murakami J; Ohama K
    Oncol Rep; 1999; 6(2):325-8. PubMed ID: 10022998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Protease-antiprotease balance in patients with invasive carcinoma of the cervix and uterus before and after radiotherapy].
    Benítez-Bribiesca L; de la Huerta-Sánchez R; Villanueva C; Freyre Horta R; Pastrana L; Guevara R
    Arch Invest Med (Mex); 1989; 20(1):9-21. PubMed ID: 2788398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cathepsin D and B activity in the serum of patients with urothelial bladder cancer].
    Guszcz T; Swieczkowska M; Milewska E; Gorodkiewicz E; Kozłowski R; Roszkowska-Jakimiec W
    Pol Merkur Lekarski; 2014 Jun; 36(216):386-8. PubMed ID: 25095637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histoenzymological study on desquamative cervico-vaginal cells.
    Taşcă L; Onicescu D
    Morphol Embryol (Bucur); 1977; 23(3):195-200. PubMed ID: 142910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum proteinase levels, platelet functional and morphological alterations in patients with cervix uteri carcinoma. Correlation with the degree of progression of the malignancy.
    Benítez-Bribiesca L; Villanueva C; Freyre R; Amezcua JL; de la Huerta R; Luévano E; Pastrana L
    Arch Invest Med (Mex); 1986; 17(2):211-42. PubMed ID: 3109344
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cytofluorimetric research on the epithelium of the cervix uteri in malignancy].
    Ganina KP; Nosa PP; Boroda AN; Klevetenko MP
    Tsitol Genet; 1993; 27(2):30-7. PubMed ID: 8212323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinase 9 in the uterine cervix during tumor progression.
    Talvensaari-Mattila A; Turpeenniemi-Hujanen T
    Int J Gynaecol Obstet; 2006 Jan; 92(1):83-4. PubMed ID: 16233897
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunohistochemical detection of the placental form of glutathione S-transferase in dysplastic and neoplastic human uterine cervix lesions.
    Shiratori Y; Soma Y; Maruyama H; Sato S; Takano A; Sato K
    Cancer Res; 1987 Dec; 47(24 Pt 1):6806-9. PubMed ID: 3499981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protease and antiprotease concentrations in serum and vaginal fluid of patients with carcinoma of the cervix.
    Benítez-Bribiesca L; Freyre-Horta R; Gallegos-Vargas G
    Arch Invest Med (Mex); 1980; 11(4):523-45. PubMed ID: 7011240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.